Трокулеуцел

Troculeucel

МНН

Rec. INN (наименование, зарегистрированное ВОЗ)

Химическое название

autologous natural killer (NK) cells isolated from peripheral blood leukapheresis of individual healthy donors. The leukapheresis material is enriched for CD56+ cells by positive immunoselection and re-suspended in media containing fetal bovine serum (FBS), interleukin-2 (IL-2), and interleukin-21 (IL-21). The cells are initially cultured in media containing IL-2 and two different irradiated feeder cell lines and then cultured with IL-2 alone to induce cell expansion.
The final cell population consists of CD3-CD56+ NK cells (≥80%), with highly expressed activating NK cell receptors [NKp30, NKp44 and NKp46, C-type lectin-like receptor (NKG2 family of receptors including NKG2C and NKG2D)], and other activating receptors such as CD16 and CD244. The cells also upregulate expression of perforin-1, granzyme, tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ) and CD107a, and demonstrate cytotoxicity against K562 myeloid leukemia cells in vitro (≥50%)

Иностранные названия

Поделиться этой страницей

Подробнее по теме

Узнайте дополнительные сведения о действующем веществе Трокулеуцел: